Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]DPA-714 PET Imaging in Asymptomatic Carotid Artery Disease
NCT05238961Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2028
- Primary completion
- Apr 2028
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of DPA-714 in carotid artery disease (2 cohorts), sponsored by University of Alabama at Birmingham. Primary endpoint: Total volume distribution of the regional time-activity curves from the TSPO- PET Data at 48 hours. Planned start Apr 2028; status: withdrawn.
02
Drugs
DPA-714
03
Conditions
carotid artery disease
Beyond the preview
Go deeper on NCT05238961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05238961.